What is Cancer Marker Tests ?
The cancer marker is the substance that is produced by the body in response to cancer or produced by the cancer cell itself. Testing for cancer markers is usually performed by taking a sample of blood or urine to analyze for specific or multiple cancer markers.
Benefit
- Several screening tests have been shown to detect cancer early and to reduce the chance of dying from that cancer.
- These tests are very important and repeated regularly in patients with confirmed cancer with or without treatment. They are performed to monitor responses to cancer treatment (during the treatment process) or to detect the recurrence of cancer (after treatment completion) in these patients. In medicine, this is called tertiary prevention.
- has more potential benefits than harms (possible harms of screening tests include bleeding or other physical damage, false-positive or false-negative test results, and overdiagnosis—the diagnosis of cancers that would not have caused problems and did not need treatment)
WHO

5/5
- People aged 40 to 74 years above should ask a healthcare provider if they should have a cancer-related checkup
2. Person who has been diagnosed with a pre-cancerous condition
3.People who have a family history of cancer.
GF-CMP1
For Male
RM
119
-
AFP (Alpha-fetoprotein)
-
CEA (Carcinoembryonic Antigen)
-
PSA (Prostate-specific antigen)
-
CA 19.9 (Cancer Antigen 19.9)
GF-CMP2
For Female
RM
159
-
AFP (Alpha-fetoprotein)
-
CEA (Carcinoembryonic Antigen)
-
CA 15.3 (Cancer Antigen 15.3)
-
CA 125 (Cancer Antigen 125)
-
CA 19.9 (Cancer Antigen 19.9)